Amanda Bulman

Mrs. Amanda Bulman

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2021 in Beverages
Verified
Journal Article
Open access
PDF file
ABAmanda Bulman
Amanda Bulman
NDNathan D'Cunha
Nathan D'Cunha
WMWolfgang Marx
Wolfgang Marx
Andrew McKuneAndrew McKune
Andrew McKune
RJRati JANI
Rati JANI
Nenad NaumovskiNenad Naumovski
Nenad Naumovski
Functional beverages can be a valuable component of the human diet with the ability to not only provide essential hydration but to deliver important bioactive compounds that can contribute to chronic disease treatment and prevention. One area of the functional beverage market that has seen an increase in demand in recent years are beverages that promote relaxation and sleep. Sleep is an essential biological process, with optimal sleep being defined as one of adequate duration, quality and timing. It is regulated by a number of neurotransmitters which are, in turn, regulated by dietary intake of essential bioactive compounds. This narrative review aimed to evaluate the latest evidence of the sleep promoting properties of a selection of bioactive compounds (such as L-theanine and L-tryptophan) for the development of a functional beverage to improve sleep quality; and the effectiveness of traditional sleep promoting beverages (such as milk and chamomile). Overall, the bioactive compounds identified in this review, play essential roles in the synthesis and regulation of important neurotransmitters involved in the sleep-wake cycle. There is also significant potential for their inclusion in a number of functional beverages as the main ingredient on their own or in combination. Future studies should consider dosage; interactions with the beverage matrix, medications and other nutraceuticals; bioavailability during storage and following ingestion; as well as the sensory profile of the developed beverages, among others, when determining their effectiveness in a functional beverage to improve sleep quality.

14 June 2022 in Diabetology
Verified
Journal Article
Open access
PDF file
MKMatina Kouvari
Matina Kouvari
DSDomenico Sergi
Domenico Sergi
NDNathan D'Cunha
Nathan D'Cunha
ABAmanda Bulman
Amanda Bulman
DPDemosthenes Panagiotakos
Demosthenes Panagiotakos
Nenad NaumovskiNenad Naumovski
Nenad Naumovski
The prevalence of non-alcoholic fatty liver disease (NAFLD) and its progressive form, non-alcoholic steatohepatitis (NASH), is increasing in parallel with the rising rates of obesity and type 2 diabetes. Approximately one in four adults are diagnosed with liver steatosis globally. NAFLD is associated with insulin resistance, hypertension, obesity, visceral adiposity, and dyslipidaemia. These risk factors are often accompanied by inflammation and oxidative stress, which also play a role in extrahepatic diseases, including conditions related to the central nervous system, such as mild cognitive impairment and Alzheimer’s disease. The number of people living with dementia is approximately 55 million and is estimated to increase to approximately 2 billion people by 2050. Recent studies have found that NAFLD is associated with poorer cognition. The aim of this review was to summarise the findings of hitherto studies that have linked NAFLD with cognition and dementia, as well as to discuss the potential liver–brain pathways.

15 April 2026 in Contemporary Clinical Trials
Verified
Journal Article
Open access
ABAmanda Bulman
Amanda Bulman
AMAndrew McKune
Andrew McKune
EGEkavi Georgousopoulou
Ekavi Georgousopoulou
DSDomenico Sergi
Domenico Sergi
Nenad NaumovskiNenad Naumovski
Nenad Naumovski
L-theanine (L-THE) is a non-proteinogenic amino acid predominantly found in the leaves of the tea plant, Camelia sinensis, whose varieties produce green, white, oolong, black, aged Pu-erh, and ripened Pu-erh teas. The potential nootropic effects of L-THE, particularly for alleviating stress and anxiety and improving sleep quality, have seen an increase in its commercial application in products such as functional beverages and supplements despite the lack of conclusive evidence in the literature. The aim of this research project was to evaluate the effects of different concentrations of L-THE, in the form of a functional beverage sachet, on sleep and stress markers in individuals with mild to moderate sleep disturbances and determine an optimal concentration. In this randomised, double-blind, placebo-controlled, parallel-group, four-arm, dose response intervention trial, sixty healthy participants aged 18-65 with mild to moderate sleep disturbances were recruited to the study (UCHREC Approval Number: 2023-13247 and ACTRN12623000776606; Universal Trial Number (UTN) is U1111-1292-0328). Enrolled participants were randomly allocated to one of four treatment arms (100mg L-THE, 200mg L-THE, 400mg L-THE or placebo) in a 1:1:1:1 ratio, where they consumed a functional beverage for 14-days following a 7-day baseline period. The primary outcomes of this study were changes from baseline in objective and subjective sleep quality parameters alongside changes in secondary outcome measures of biochemical, physiological, and subjective stress markers relative to baseline. This clinical trial is the first to comprehensively evaluate the effectiveness (optimal dose) of L-THE at improving sleep quality and stress markers using a suite of objective, subjective, physiological, and biochemical tools.

14 November 2023 in Proceedings
Verified
Conference Paper
Open access
PDF file
ABAmanda Bulman
Amanda Bulman
NDNathan D'Cunha
Nathan D'Cunha
WMWolfgang Marx
Wolfgang Marx
MTMurray R. Turner
Murray R. Turner
Andrew McKuneAndrew McKune
Andrew McKune
Nenad NaumovskiNenad Naumovski
Nenad Naumovski
Background/Objectives: Sleep disturbances are considered a major public health issue due to their negative impact on overall health and the economy. There is an increasing interest in plant bioactive compounds as natural alternatives to common pharmaceutical treatment options for improving sleep quality. The green tea amino acid, L-theanine (L-THE), has been shown to induce relaxation, reduce stress, anxiety, and depressive symptoms by influencing the several neurotransmitters associated with the sleep–wake cycle. Therefore, the aim of this systematic literature review was to evaluate the effects of L-THE consumption on sleep quality in humans. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines, systematic literature searches were conducted in six electronic databases (PsycINFO, CINAHL, Web of Science, Medline, Scopus, and Cochrane Central Register of Controlled Trials). This systematic literature review was pre-registered with the international prospective register of systematic reviews PROSPERO (CRD42022304635). Results/Discussion: In total, eleven journal articles were identified that met the inclusion criteria where L-THE supplementation (alone or in combination with other bioactives) was compared to the supplementation of a placebo (or comparator) for the treatment of sleep disturbances. The duration of treatments varied from one day to eight weeks. The majority of the included studies were conducted in adults (n = 373) while two studies were completed in children (n = 107). Improvements in several sleep parameters were observed including sleep onset latency (7), total sleeping time (2), sleep duration (2), sleep efficiency (2), overall sleep quality (5), daytime dysfunction (2), early awakenings (1), morning sleepiness (3), the use of sleep medication (1), and sleep disturbances (4) (All p’s < 0.05). The findings indicate that L-THE (50–655 mg) may be effective at improving sleep quality either as an individual supplement or in combination with other bioactives. Furthermore, the treatment of sleep disturbances with L-THE at doses higher than 655 mg may not be beneficial and may be detrimental to overall sleep quality. Conclusion: The findings of this systematic literature review indicate promising effects on the use of L-THE in the management of sleep disturbances and highlight the need for further studies to determine if there is an optimal concentration of L-THE for improving sleep.